The Economic Times

Dr. Reddys Laboratories shares in focus after acquiring India trademarks for two HRT drugs for $32 million

Dr. Reddy's Laboratories is set to attract investor attention after acquiring the India trademarks for specialty brands Progynova and Cyclo-Progynova from Mercury Pharma Group Limited for USD 32.15 million. This domestic acquisition significantly strengthens Dr. Reddy's gynecology portfolio and marks its entry into the Hormone Replacement Therapy segment in India.